Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (CAI)

CUSIP: 142152107

Q1 2026 13F Holders as of 31 Mar 2026

Security type / class
Equity / Common Stock, par value $0.001 per share
Total 13F shares
156,665,947
Total 13F value
$2,797,623,495
Holder snapshot 6 visible 7 signals
Share change
+3,437,743
Put/Call ratio
113%
SEC-reported price per share
$17.88
Number of holders
200
Value change
-$13,710,474
Number of buys
137
Open additional details 1 more signal available
Number of sells
73
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
282,066,647

Security key

142152107

Report period

Q1 2026

Institutions

200

Top holders

10

CAI full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 Previous quarter: Q4 2025 Caris Life Sciences, Inc. SEC filings Caris Life Sciences, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CAI - Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
David D. Halbert
Disclosed value leader
David D. Halbert
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G 13F 3/4/5 Lead comparable stake: 44% 13D/G row: David D. Halbert Showing 1-6 of 15 holder rows.

Quick read

David D. Halbert leads the comparable SEC ownership view at 44%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens David D. Halbert's linked filing trail.
Comparable ownership Top 5
David D. Halbert 44%
FMR LLC 11%
J H Whitney VI L P 6.5%
TSSP Sub-Fund HoldCo LLC 5.1%
RIVERVIEW GROUP LLC 1.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
David D. Halbert
13D/G
13D/G
44%
$3,311,265,907
124,906,296 shares
 $0 30 Jun 2025
FMR LLC
13D/G 13F
Company
13D/G 13F
11%
$547,689,677
30,631,585 shares
 +$294,800,519 31 Mar 2026
J H Whitney VI L P
13D/G 3/4/5
10%+ Owner
13D/G 3/4/5
6.5%
$329,531,901
18,256,615 shares
 -$36,100,000 31 Mar 2026
TSSP Sub-Fund HoldCo LLC
13D/G 3/4/5
Alan Waxman · Former 10% Owner
13D/G 3/4/5
5.1%
$259,656,452
14,385,399 shares
 -$90,250,000 31 Mar 2026
RIVERVIEW GROUP LLC
13D/G
Millennium Management LLC
13D/G
1.3%
—
3,583,100 shares
 $0 17 Jun 2025
Peter M. Castleman
3/4/5
Director
3/4/5
3.7%
$275,313,217
10,395,044 shares
 — 26 Feb 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
200
Shares
156,665,947
Rows available
200
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
184
Q1 2026 holders
200
Holder diff
16
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .